Drugs / Autogenous Demineralized Dentin Matrix
Autogenous Demineralized Dentin Matrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07652216 | Apr 2024 → Dec 2026 expected | dentigerous cyst, impacted teeth, multiple | Jagiellonian University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autogenous Demineralized Dentin Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07652216 ↗ |
| Modality | Other / unclassified | “Autogenous Dentin Demineralized Matrix (ADDM) has been introduced as a biomaterial supporting bone regeneration and defect filling.” NCT07652216 ↗ |